Erste Asset Management GmbH Increases Holdings in Masimo Co. (NASDAQ:MASI)

Erste Asset Management GmbH boosted its stake in shares of Masimo Co. (NASDAQ:MASI) by 50.3% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 82,652 shares of the medical equipment provider’s stock after buying an additional 27,652 shares during the period. Erste Asset Management GmbH owned 0.15% of Masimo worth $13,934,000 at the end of the most recent quarter.

Several other large investors also recently added to or reduced their stakes in the stock. Smartleaf Asset Management LLC lifted its holdings in Masimo by 31.6% in the fourth quarter. Smartleaf Asset Management LLC now owns 250 shares of the medical equipment provider’s stock valued at $42,000 after acquiring an additional 60 shares during the last quarter. EverSource Wealth Advisors LLC lifted its stake in shares of Masimo by 40.0% in the 4th quarter. EverSource Wealth Advisors LLC now owns 224 shares of the medical equipment provider’s stock valued at $37,000 after purchasing an additional 64 shares during the last quarter. Blue Trust Inc. grew its holdings in shares of Masimo by 56.3% during the 4th quarter. Blue Trust Inc. now owns 197 shares of the medical equipment provider’s stock worth $33,000 after purchasing an additional 71 shares during the period. CIBC Asset Management Inc increased its position in shares of Masimo by 5.6% during the 4th quarter. CIBC Asset Management Inc now owns 1,631 shares of the medical equipment provider’s stock worth $270,000 after purchasing an additional 87 shares during the last quarter. Finally, MML Investors Services LLC raised its holdings in Masimo by 4.9% in the 3rd quarter. MML Investors Services LLC now owns 2,056 shares of the medical equipment provider’s stock valued at $274,000 after buying an additional 96 shares during the period. 85.96% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several brokerages have weighed in on MASI. Piper Sandler increased their target price on shares of Masimo from $210.00 to $215.00 and gave the stock an “overweight” rating in a research note on Wednesday, February 26th. Needham & Company LLC reaffirmed a “hold” rating on shares of Masimo in a research report on Wednesday, February 26th. Stifel Nicolaus reissued a “buy” rating and issued a $190.00 target price (up previously from $170.00) on shares of Masimo in a research report on Friday, November 22nd. Wells Fargo & Company upped their price target on Masimo from $193.00 to $205.00 and gave the stock an “overweight” rating in a research note on Wednesday, February 26th. Finally, Raymond James lifted their price objective on Masimo from $170.00 to $194.00 and gave the company an “outperform” rating in a research note on Friday, December 27th. Two equities research analysts have rated the stock with a hold rating and five have given a buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $194.80.

Insider Transactions at Masimo

In related news, COO Bilal Muhsin sold 30,000 shares of the firm’s stock in a transaction that occurred on Monday, March 10th. The stock was sold at an average price of $167.49, for a total transaction of $5,024,700.00. Following the transaction, the chief operating officer now owns 24,172 shares in the company, valued at $4,048,568.28. This trade represents a 55.38 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Insiders own 9.70% of the company’s stock.

Masimo Price Performance

MASI stock opened at $165.69 on Friday. The business’s 50-day moving average is $174.90 and its two-hundred day moving average is $157.02. The firm has a market capitalization of $8.94 billion, a P/E ratio of 114.27 and a beta of 1.03. Masimo Co. has a 1 year low of $101.61 and a 1 year high of $194.88. The company has a debt-to-equity ratio of 0.50, a current ratio of 2.01 and a quick ratio of 1.11.

Masimo (NASDAQ:MASI) last issued its earnings results on Tuesday, February 25th. The medical equipment provider reported $1.80 earnings per share for the quarter, topping the consensus estimate of $1.42 by $0.38. The business had revenue of $600.70 million for the quarter, compared to analyst estimates of $593.35 million. Masimo had a return on equity of 14.98% and a net margin of 3.85%. Analysts anticipate that Masimo Co. will post 4.1 earnings per share for the current fiscal year.

Masimo Profile

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.